Heartflow's Participation in the Piper Sandler Healthcare Conference
MOUNTAIN VIEW, Calif. — Heartflow, Inc. (Nasdaq: HTFL), a pioneer in artificial intelligence (AI) technology aimed at combatting coronary artery disease (CAD), has revealed plans for significant engagement in a fireside chat during the Piper Sandler 37th Annual Healthcare Conference. This notable event will occur on a designated day where management will share insights into the company's cutting-edge approaches to cardiovascular care.
Understanding Heartflow's Mission
Heartflow is at the forefront of transforming the way coronary artery diseases are diagnosed and treated. By utilizing advanced AI technology, the company is not just innovating healthcare but is also making strides in redefining patient experiences. With a focus on precision medicine, Heartflow leverages the largest coronary imaging dataset globally, impacting countless lives.
The Value of AI in Cardiovascular Care
Through their pioneering solutions, Heartflow has gained trust across over 1,400 healthcare institutions worldwide. Their platform enables clinicians to provide more efficient and effective care. The technology stands out as it allows for the generation of personalized 3D models from coronary CTA images. This not only aids in accurate diagnosis but also enhances treatment planning, ensuring the best outcomes for patients.
Clinical Integration and Research Validation
Heartflow’s platform isn’t just theoretical; it is backed by solid clinical research. More than 100 studies involving over 365,000 patients have validated the effectiveness of Heartflow’s AI-driven solutions. This extensive research demonstrates the reliability and accuracy of their advanced diagnostic tools, which boast an impressive acceptance rate of coronary CTA images exceeding 96%.
Key Features of Heartflow’s Technology
Heartflow’s groundbreaking technology offers several key features that make it a leader in the cardiovascular care space:
- Proprietary Data Pipeline: With over 110 million annotated CTA images, Heartflow’s extensive data foundation empowers advanced AI models. These models provide highly precise and reproducible insights tailored to diverse patient populations.
- Clinical Validation: The AI solutions from Heartflow are not only innovative but have also undergone rigorous clinical validation, showing consistent performance in real-world settings.
- Workflow Integration: Heartflow’s solutions ensure clinicians receive quality-reviewed analyses instantly. This empowers healthcare professionals to make informed decisions swiftly and efficiently.
- Compliance and Security: With a commitment to the highest standards, Heartflow meets or exceeds international benchmarks for security and patient data integrity, including certifications like HITRUST and SOC 2 Type 2.
About Heartflow, Inc.
Heartflow is dedicated to transforming the approach to coronary artery disease, developing solutions that allow for early detection, accurate diagnosis, and effective management of the condition. The Heartflow One platform utilizes AI technology to create comprehensive 3D models of the heart, offering crucial insights into plaque characteristics and their impact on blood circulation — all while minimizing the need for invasive procedures.
Investor and Media Contact
For inquiries, investors can reach out to Nick Laudico via email at nlaudico@heartflow.com. Media inquiries can be directed to Elliot Levy at elevy@heartflow.com.
Frequently Asked Questions
What is Heartflow's primary technology?
Heartflow specializes in AI solutions for coronary artery disease, creating accurate 3D models from CTA images to enhance diagnosis and treatment.
How many institutions have adopted Heartflow's technology?
Over 1,400 healthcare institutions worldwide have adopted Heartflow’s innovative technology for cardiovascular care.
What are the key benefits of Heartflow's AI models?
Heartflow's AI models deliver precise insights, streamline clinical workflows, and significantly improve patient outcomes through rapid analysis.
How does Heartflow validate its technology?
Heartflow’s solutions have undergone rigorous clinical validation supporting their use in real-world clinical practice with high acceptance rates.
Who can I contact for more information about Heartflow?
For further details, investors can contact Nick Laudico, and media inquiries can go to Elliot Levy through their provided emails.
